Our Specialty Therapeutics team is focused on supporting science-driven innovation by providing actionable insights and developing strategies for success in diseases with significant residual unmet need.

 

Evolving Specialty Therapeutics Landscape
An increasing understanding of the underlying disease biology and the possibility of leveraging disease pathway commonalities to develop assets with broad applicability
Personalized therapies (based on patient clustering using molecular & cytokine signature, biomarkers and patient phenotypes) in development
The potential for early intervention in the disease continuum to reduce disease progression and improve patient outcomes
The emergence of advanced technology platforms such as cell and gene therapies

 

How We Can Help: SmartAnalyst can help sharpen asset development focus; we bring the right mix of scientific and commercial expertise, customized to each project

  • We start with the science, harnessing the exponential increase in the understanding of diseases and future innovation.
  • We understand the commercial considerations and key business decisions that need to be made.
  • We bring strong relationships with key opinion leaders (KOLs) – a robust database of immunology, hematology and neurology experts, among others, helps us provide core insights to clients across geographies.
  • We have completed over 250 projects for disease strategy, asset strategy, franchise strategy, and business development for leading pharma and bio-pharma companies.